Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

January 3, 2023

Study Completion Date

January 7, 2024

Conditions
Sickle Cell Disease
Interventions
DRUG

L-Glutamine, Oral Powder for Reconstitution

Glutamine is an essential amino acid. It will be provided in a powder form. It will be dissolved in at least 8 ounces of hot or cold liquid. It can also be mixed with a soft food such as pudding, applesauce, or yogurt. Then it will be Stirred and then eaten or drunken The Glutamine will be as an add on to the Standard of care

OTHER

Standard of care

Hydroxyurea 15-25 mg per kg per day and/ or blood transfusion therapy

Trial Locations (2)

11566

Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05371184 - Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients | Biotech Hunter | Biotech Hunter